Drugs in prisons: Exploring use, control, treatment and policy

Kolind, Torsten; Duke, Karen L.

doi:10.3109/09687637.2016.1153604

Cited by 33 publications

(29 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The situation is also exacerbated by prison officers confiscating syringes, which limits the number left, increasing the use of shared needles [22]. HIV and HCV is reportedly 15-39 times higher among prisoners than the general population, inmates with HIV may cost the correctional system in the United States at least $10,000 a year on top of all other expenses [13,21,37].…”

Section: Hiv/sharing Syringesmentioning

confidence: 99%

“…Prisons become an effective vehicle for spreading drug use because it is easy for drug users to establish social relationships and pass on their drug habit, due to peer pressure and power of association. The main reasons for using drugs in prisons are reportedly, to relieve insomnia, boredom (due to a lack of constructive activities) and as a coping mechanism [11][12][13][14]. Drug using prisoners generally experience deprivation, poor education achievements together with unemployment issues, which inevitably lead to poor housing [13].…”

mentioning

confidence: 99%

See 1 more Smart Citation

Behind Bars: The Truth about Drugs in Prisons

O'Hagan

Hardwick

2017

FRCIJ

View full text Add to dashboard Cite

Section: Hiv/sharing Syringesmentioning

confidence: 99%

mentioning

confidence: 99%

Behind Bars: The Truth about Drugs in Prisons

O'Hagan

Hardwick

2017

FRCIJ

View full text Add to dashboard Cite

“…Following an extensive literature review on studies covering the prevalence, cause and perceptions about drug use amongst individuals including the prisoners, a draft questionnaire was designed in order to cover the areas of our interest in this study . The questionnaire was modified and some questions were suggested by the researchers of the study.…”

Section: Methodsmentioning

confidence: 99%

Drug abuse in Syria: pattern of use, causes and perception as perceived by Syrian addicts

Abazid

Abou‐Isba

Farha

et al. 2020

J Pharm Health Serv Res

View full text Add to dashboard Cite

Objectives We aimed to evaluate the current pattern, causes and attitude towards drug use amongst Syrian prisoners who were incarcerated due to their using drugs. Methods This is a descriptive cross-sectional survey-based study that was conducted over a period of six months. Prisoners were recruited from two main civil prisons in Syria. The data collected in this study were through the use of a self-administered survey. The prisoners were met in a separate room away from their dormitories and they were asked to fill out the survey after obtaining their verbal consent. Keyfindings A total of 50 participants were recruited (response rate = 66.7%). Most of the prisoners (n = 29, 58.0%) started to use drugs at a friend's home, and the most commonly used drug was Hashish (weed and cannabis) (n = 22, 44.0%). Two-thirds of the participants (n = 34, 68.0%) said that they returned to drugs after quitting. The most common reason was using drugs for euphoria (n = 12, 24.0%). Regarding prisoners' beliefs about different causes of drug use, curiosity was found to be the most common cause of drug use (n = 19, 38.0%). Surprisingly, prisoners incorrectly believed that they can take drugs and they can stop them whenever they want (n = 34, 68.0%) and that drug use does not lead to addiction (n = 30, 60.0%).Conclusions The findings of this study indicate the need to devote more attention to family and peer influences on an individual's behaviour by policymakers, in developing preventive strategies. As well as, the need to raise the awareness of individuals in the society about drug use, subsequently, changes their incorrect perceptions towards drugs through several strategies including educational programmes as well as workshops whether in school, universities or social media.

show abstract

“…Le cause della dipendenza riconoscono una origine multifattoriale, basata su elementi di vulnerabilità che possono essere individuali, sociali, ambientali e genetici [14]. Durante la detenzione gli elementi di vulnerabilità individuali, che hanno portato un soggetto a consumare sostanze, possono acutizzarsi e favorire il craving, il consumo di sostanze e i processi di ricaduta nell'uso [15][16][17]. Per queste ragioni uno degli obiettivi primari della presa in carico del consumatore di sostanze in carcere è la stabilizzazione del sintomo attraverso la somministrazione della terapia agonista.…”

Section: Le Indicazioni All'uso Della Terapia Agonista In Carcereunclassified

Management of buprenorphine/naloxone therapy in substances abuse consumers in prison: efficacy and safety

Nava¹

2018

abtpn

View full text Add to dashboard Cite

The use of agonist therapy in prison is not widespread in Italy or in the rest of the world. This causes a strong limitation in access to care for inmates, but above all causes serious negative consequences on public health, due to the lack of treatment of a population otherwise difficult to reach. This population, if left untreated, presents greater risks, when discharged from jail, of relapse in use, of infectious diseases occurrence and of death by overdose. Inappropriate treatment also causes a greater difficulty in the management of the inmate: several behavioral disorders, such as self-harm, self and hetero-aggression, and suicide attempts, can be prevented through an appropriate use of agonist therapy. One of the primary objectives in the management of illicit substance users is the increase in the proper use of agonistic treatments, in their duration and dosage and the improvement of their safety profile through the prevention of episodes of misuse and/or diversion. This can be achieved through the use of partial agonist drugs and abuse-deterrent formulations such as buprenorphine/naloxone (Pharmacology)

show abstract

Drugs in prisons: Exploring use, control, treatment and policy

Cited by 33 publications

References 36 publications

Behind Bars: The Truth about Drugs in Prisons

Behind Bars: The Truth about Drugs in Prisons

Drug abuse in Syria: pattern of use, causes and perception as perceived by Syrian addicts

Management of buprenorphine/naloxone therapy in substances abuse consumers in prison: efficacy and safety

Contact Info

Product

Resources

About